文献速递心脏核医学

心脏冲击波治疗对严重冠心病患者的疗效与安全性:随机双盲对照研究

Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study.
PubMed 文献 · J Nucl Cardiol · 2021-09-02

结果显示CSWT组在区域负荷评分、缺血面积负荷改善率及缺血面积差值改善率上显著优于对照组,临床症状、生活质量和6分钟步行距离两组均改善但组间无显著差异,血流动力学稳定且心肌损伤标志物无变化。

要点

  • 临床症状、生活质量和6分钟步行距离两组均改善但组间无显著差异。

核心结论

  • CSWT可有效且安全地改善严重冠心病患者的心肌灌注。
  • 临床症状、生活质量和6分钟步行距离治疗后均改善,但两组间无显著差异。

研究设计与样本

  • 患者随机分为CSWT组或对照组,3个月内共进行9次冲击波治疗,CSWT组接受真实治疗,对照组接受假治疗。

主要发现

  • 西雅图心绞痛问卷、生活质量(QOL)和6分钟步行试验(6MWT)距离两组均改善,但组间无显著差异。
  • 治疗过程中血流动力学参数稳定,两组心肌损伤标志物均无变化。

临床怎么用

  • 对于不适合血运重建、经最佳药物治疗后仍有明显缺血的严重冠心病患者,CSWT可作为改善心肌灌注的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies proved the efficacy of cardiac shock wave therapy (CSWT) for coronary artery disease (CAD) patients who are not candidate for reperfusion therapy. Randomized control trials are limited. We try to explore the efficacy and safety of CSWT for patients with severe CAD. METHODS: Thirty patients with severe CAD who had obvious ischemia on myocardial perfusion imaging (MPI) were enrolled and randomly assigned to the CSWT group or the control group. They had received optimal medication treatment for at least three months. Nine sessions of shock wave therapy were conducted over 3 months. CSWT group received the real treatment, while the control group received the pseudo-treatment. Clinical symptom, imaging outcomes and safety parameters were compared between two groups. RESULTS: After treatment, regional stress score (P = .023), improvement rate (IR) of ischemic area (IA) stress (P < .001) and IR of IA difference (P < .001) were significantly favor CSWT group. The interaction of summed rest score (P < .001), summed stress score (P = .004), summed difference score (P = .036) were significantly improved in the CSWT group compared to the control group. Seattle angina questionnaire, quality of life (QOL) and the distance of six-minute walking test (6MWT) were improved in both groups without significant difference between them. Hemodynamic parameters were stable during procedure. Myocardial injury markers showed no changes in two groups. CONCLUSIONS: Our study demonstrated CSWT could effectively and safely improve myocardial perfusion in patients with severe CAD. Clinical symptom, QOL and 6MWT were all improved after treatment, but no significant difference between two groups.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Jia N, Zhang R, Liu B, et al. Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study. J Nucl Cardiol. 2021. PMID: 34476776. doi:10.1007/s12350-021-02768-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。